BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/22/2022 6:17:12 AM | Browse: 909 | Download: 1822
Publication Name World Journal of Clinical Oncology
Manuscript ID 65123
Country Türkiye
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Minireviews
Article Title Role of radiotherapy in oligometastatic breast cancer: Review of the literature
Manuscript Source Invited Manuscript
All Author List Caglayan Selenge Beduk Esen, Melis Gultekin and Ferah Yildiz
ORCID
Author(s) ORCID Number
Caglayan Selenge Beduk Esen http://orcid.org/0000-0001-9967-8177
Melis Gultekin http://orcid.org/0000-0002-1806-2619
Ferah Yildiz http://orcid.org/0000-0002-2557-8103
Funding Agency and Grant Number
Corresponding Author Caglayan Selenge Beduk Esen, MD, Research Scientist, Department of Radiation Oncology, Hacettepe University Faculty of Medicine, Altındağ, Ankara 06100, Türkiye. selengebedk@gmail.com
Key Words Breast cancer; Oligometastatic; Radiotherapy; Locoregional treatment; Ablative therapy; Metastasis-directed therapy
Core Tip Radiotherapy (RT) has been traditionally used for only palliation of the symptoms caused by metastatic lesions. However, in recent years the concept of oligometastatic disease has been introduced in Cancer Medicine as a clinical scenario with a limited number of metastases (≤ 5) and involved organs (≤ 2) with controlled primary tumor. The main hypothesis in oligometastatic disease is that locoregional treatment of primary tumor site and metastasis-directed therapies with surgery and/or RT may improve outcomes. The current review will provide up-to-date information about the role of RT in oligometastatic breast cancer.
Publish Date 2022-01-22 06:17
Citation Beduk Esen CS, Gultekin M, Yildiz F. Role of radiotherapy in oligometastatic breast cancer: Review of the literature. World J Clin Oncol 2022; 13(1): 39-48
URL https://www.wjgnet.com/2218-4333/full/v13/i1/39.htm
DOI https://dx.doi.org/10.5306/wjco.v13.i1.39
Full Article (PDF) WJCO-13-39.pdf
Full Article (Word) WJCO-13-39.docx